Literature DB >> 19563334

Clinical implications of advances in the basic science of liver repair and regeneration.

S J Karp1.   

Abstract

Recent advances in our understanding of the basic mechanisms that control liver regeneration and repair will produce the next generation of therapies for human liver disease. Insights gained from large-scale genetic analysis are producing a new framework within which to plan interventions. Identification of specific molecules that drive regeneration will increase the options for live-donor liver transplantation, and help treat patients with small-for-size syndrome or large tumors who would otherwise have inadequate residual mass after resection. In a complementary fashion, breakthroughs in the ability to manipulate various cell types to adopt the hepatocyte or cholangiocyte phenotype promise to revolutionize therapy for acute liver failure and metabolic liver disease. Finally, elucidating the complex interactions of liver cells with each other and various matrix components during the response to injury is essential for fabricating a liver replacement device. This focused review will discuss how a variety of important scientific advances are likely to impact the treatment of specific types of liver disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563334     DOI: 10.1111/j.1600-6143.2009.02731.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

Review 2.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

3.  Tri-iodothyronine induces hepatocyte proliferation by protein kinase A-dependent β-catenin activation in rodents.

Authors:  Maura Fanti; Sucha Singh; Giovanna M Ledda-Columbano; Amedeo Columbano; Satdarshan P Monga
Journal:  Hepatology       Date:  2014-04-14       Impact factor: 17.425

4.  Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer.

Authors:  Elisabetta Puliga; Qian Min; Junyan Tao; Rong Zhang; Tirthadipa Pradhan-Sundd; Minakshi Poddar; Sucha Singh; Amedeo Columbano; Jinming Yu; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-08-12       Impact factor: 4.307

5.  Hepatic regenerative medicine: exploiting the liver's will to live.

Authors:  Satdarshan P S Monga
Journal:  Am J Pathol       Date:  2014-02       Impact factor: 4.307

6.  The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.

Authors:  Qiang Li; Qiang Zhao; Chuanzhao Zhang; Peng Zhang; Anbin Hu; Longjuan Zhang; Paul M Schroder; Yi Ma; Zhiyong Guo; Xiaofeng Zhu; Xiaoshun He
Journal:  J Physiol Biochem       Date:  2018-02-22       Impact factor: 4.158

7.  Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression.

Authors:  Yihuai He; Jun Long; Weiwei Zhong; Yu Fu; Ying Li; Shide Lin
Journal:  Mol Cell Biochem       Date:  2014-01-05       Impact factor: 3.396

Review 8.  Role and regulation of β-catenin signaling during physiological liver growth.

Authors:  Satdarshan Paul Singh Monga
Journal:  Gene Expr       Date:  2014

9.  Gliotoxin-induced changes in rat liver regeneration after partial hepatectomy.

Authors:  Kari N Nejak-Bowen; Anne V Orr; William C Bowen; George K Michalopoulos
Journal:  Liver Int       Date:  2013-04-01       Impact factor: 5.828

10.  Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration.

Authors:  Tamara Feliciano Alvarado; Elisabetta Puliga; Morgan Preziosi; Minakshi Poddar; Sucha Singh; Amedeo Columbano; Kari Nejak-Bowen; Satdarshan P S Monga
Journal:  Gene Expr       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.